Home  >  News
Eppen_CellXpert_Mar2026
you can get e-magazine links on WhatsApp. Click here
News
  MetaVia expands global patent protection for vanoglipel, supporting metabolic and liver disease therapy through 2035,   March 13, 2026
  Co-Diagnostics’ Co-Dx PCR Platform Technologies receives Japanese Patent,   March 13, 2026
  Immunic receives European patent protecting relevant dosing regimens for vidofludimus calcium,   March 12, 2026
  XYRA gets US patent protecting use of dose adjusted budiodarone to treat AF, with monitoring to correspondingly reduce/delay risk of stroke and/or congestive heart failure,   March 06, 2026
  CollPlant Biotechnologies’ photocurable dermal filler technology receives Korean Patent,   February 28, 2026
  Melodia Therapeutics receives US patent covering MLD-151,   February 27, 2026
  Genprex to receive Japanese and EU patents for Reqorsa Gene Therapy in combination with immunotherapies to treat cancer,   February 25, 2026
  Envoy Medical receives 3 new patents to strengthen position in cochlear implant sector,   February 25, 2026
  Japan Patent Office issues a notice of allowance to Moleculin Biotech for patent application covering annamycin,   February 19, 2026
  Altamira Medica’s Bentrio nasal spray receives notice of allowance from Japan Patent Office,   February 16, 2026
  Astellas reaches settlement agreement with Lupin in Myrbetriq patent litigation,   February 11, 2026
  Diamyd Medical receives Notice of Allowance for key retogatein US patent,   February 10, 2026
  Marvel Biosciences’ lead therapeutic candidate, MB-204 receives Japanese patent,   February 05, 2026
  Acurx Pharmaceuticals’ DNA Polymerase IIIC inhibitors receives US patent,   February 04, 2026
  Longeveron receives Japanese patent for potency assay methods to assess human mesenchymal stem cells,   January 31, 2026
  AB Science receives Japanese patent for use of masitinib in progressive forms of multiple sclerosis,   January 23, 2026
  Alto Neuroscience receives US patent for ALTO-207; strengthens IP portfolio for patients with treatment-resistant depression,   January 17, 2026
  Newron Pharmaceuticals expands IP portfolio for evenamide with new European Union composition of matter patent,   January 08, 2026
  Novo Nordisk announces China’s Supreme People’s Court delivers positive ruling on semaglutide compound patent,   January 03, 2026
  Hoth Therapeutics expands oncology pipeline with dual patent filings establishing novel oncology dermatology IP platform,   January 03, 2026

 Back
 
Propak_Asia_2026
CP_CPHI_Korea2026
IWE_CP_2026
ChemExpo_India_2026
PharmaTech_expo_Chandigarh2026
ASIA_PHARMA_EXPO_2026
CPHI_Japan26
Ana_Lab_India_2026
PharmaCore_India_2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram